Hypoglycemia due to Ectopic Secretion of Insulin-Like Growth Factor-I in a Patient with an Isolated Sarcoidosis of the Spleen

  • OGIWARA Yuiko
    Department of Diabetes, Metabolism and Endocrinology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
  • MORI Seijiro
    Department of Diabetes, Metabolism and Endocrinology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
  • IWAMA Mizuki
    Molecular Regulation of Aging, Research Team for Functional Biogerontology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
  • SAWABE Motoji
    Department of Pathology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
  • TAKEMOTO Minoru
    Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan
  • KANAZAWA Nobuo
    Department of Surgery, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
  • FURUTA Koh
    Department of Psychiatry, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
  • FUKUDA Izumi
    Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women’s Medical University, Tokyo, Japan
  • KONDO Yoshitaka
    Molecular Regulation of Aging, Research Team for Functional Biogerontology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
  • KIMBARA Yoshiyuki
    Department of Diabetes, Metabolism and Endocrinology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
  • TAMURA Yoshiaki
    Department of Diabetes, Metabolism and Endocrinology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
  • CHIBA Yuko
    Department of Diabetes, Metabolism and Endocrinology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
  • ARAKI Atsushi
    Department of Diabetes, Metabolism and Endocrinology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
  • YOKOTE Koutaro
    Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan
  • MARUYAMA Naoki
    Molecular Regulation of Aging, Research Team for Functional Biogerontology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
  • ITO Hideki
    Department of Diabetes, Metabolism and Endocrinology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan

Search this article

Abstract

Hypoglycemia is reported to be one of the manifestations of a patient with hypothalamic sarcoid infiltrates due to impaired counter-regulation of glucose. But, without hypothalamic lesion, patients with sarcoidosis would not be expected to have hypoglycemia. We recently identified a patient with an isolated sarcoidosis of the spleen who had experienced frequent fasting hypoglycemia which completely disappeared after splenectomy. During hypoglycemia, serum insulin was undetectable. Endocrinological examination revealed no abnormality. The objective was to investigate whether the patient’s hypoglycemia was due to ectopic secretion of an insulin-mimetic factor by the splenic sarcoidosis. Serum insulin-like growth factor-I (IGF-I) and IGF-II were measured by RIA. Serum visfatin and free IGF-I were by ELISA. A high molecular weight form of IGF-II, termed “big” IGF-II, was identified by Western blotting. Tissue IGF-I was quantified by real time RT-PCR after RNA extraction. Before operation, total and free serum IGF-I, serum IGF-II and serum visfatin were within reference range. Big IGF-II was not detected in patient’s serum extract. After operation, hypoglycemia did not recur and serum insulin returned to normal, while serum IGF-I decreased by half the preoperative level. RT-PCR revealed that mRNA level of IGF-I in the sarcoidosis tissue was about 1.8-fold greater than that in the normal spleen tissue. These data suggest that ectopic secretion of IGF-I by the splenic sarcoidosis and its direct access to the liver via the portal vein might cause fasting hypoglycemia mainly by suppressing hepatic gluconeogenesis.

Journal

  • Endocrine Journal

    Endocrine Journal 57 (4), 325-330, 2010

    The Japan Endocrine Society

Citations (3)*help

See more

References(22)*help

See more

Details 詳細情報について

Report a problem

Back to top